Stay updated on IMGN632 in BPDCN Clinical Trial
Sign up to get notified when there's something new on the IMGN632 in BPDCN Clinical Trial page.
Latest updates to the IMGN632 in BPDCN Clinical Trial page
- Check4 days agoChange DetectedLayout and formatting changes to the study page, with no modification to core content such as title, conditions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated version to v3.2.0 and added government operating-status notice; removed a previously listed condition (CD4+/CD56+ hematodermic neoplasm) and prior version tag. Overall: core content update plus new operational status info.SummaryDifference4%
- Check40 days agoChange DetectedCore terminology and versioning updated: replacing 'Acute lymphoblastic leukemia' with 'Acute lymphoid leukemia' and bumping the revision from v3.0.2 to v3.1.0.SummaryDifference0.2%
- Check54 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%
- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check68 days agoChange DetectedThe web page has been updated to include a new facility name and location in Milan, Italy, along with additional publications related to acute myeloid leukemia. Some previously listed genetic resources and location details have been removed.SummaryDifference11%
Stay in the know with updates to IMGN632 in BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN632 in BPDCN Clinical Trial page.